Risk of comorbidities in patients diagnosed with chronic urticaria: A nationwide registry-study
Background: The autoimmune profile of Chronic Urticaria (CU) patients is an increasing topic of interest. Associated diseases suggest shared pathogenic pathways, and they may provide important knowledge on specific targets for future treatment models. In this study we examined the prevalence and ris...
Main Authors: | Misbah Noshela Ghazanfar, Line Kibsgaard, Simon Francis Thomsen, Christian Vestergaard |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | World Allergy Organization Journal |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1939455119312530 |
Similar Items
-
Combined treatment with omalizumab and etanercept in a patient with chronic spontaneous urticaria and rheumatoid arthritis
by: Misbah Noshela Ghazanfar, et al.
Published: (2019-05-01) -
Biomarkers for Monitoring Treatment Response of Omalizumab in Patients with Chronic Urticaria
by: Nadja Højgaard Pedersen, et al.
Published: (2023-07-01) -
Occurrence and risk factors of mental disorders in patients with chronic urticaria
by: Misbah Noshela Ghazanfar, MD, PhD, et al.
Published: (2023-11-01) -
Home self-administration of omalizumab
by: Misbah Noshela Ghazanfar, et al.
Published: (2018-02-01) -
Comorbidities and Treatment Strategies in Bullous Pemphigoid: An Appraisal of the Existing Litterature
by: Rikke Bech, et al.
Published: (2018-09-01)